ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,507Medicare Part D Prescriptions Filled, Including Refills

Rank: 496 out of 6969

$373K Total Retail Price of All Prescriptions

Rank: 1085 out of 6969

524 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 524 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 7,899 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 742 670 1 4
OMEPRAZOLE 440 350 2 6
BENAZEPRIL HCL 350 286 3 18
METFORMIN HCL 348 289 4 7
TRAMADOL HCL 290 209 5 27
DOXAZOSIN MESYLATE 287 267 6 74
LANTUS 245 202 7 50
LEVOTHYROXINE SODIUM 239 193 8 5
SIMVASTATIN 234 179 9 1
DIOVAN 229 208 10 26
GUANFACINE HCL 219 189 R 11 378
ULTRA COMFORT 202 155 10 12 408
ATENOLOL 198 158 13 9
RAMIPRIL 189 155 14 112
LOSARTAN POTASSIUM 189 176 14 12
FAMOTIDINE 187 151 16 37
CLOPIDOGREL 165 158 17 48
TRAZODONE HCL 162 135 18 47
PRAVASTATIN SODIUM 153 131 19 19
PLAVIX 142 137 20 68
GLIMEPIRIDE 140 130 21 44
ATORVASTATIN CALCIUM 136 128 22 11
KETOCONAZOLE 129 116 23 185
LOVASTATIN 113 106 24 15
MELOXICAM 107 96 25 36
NIFEDIPINE ER 99 99 26 95
METOPROLOL SUCCINATE 97 97 27 22
GEMFIBROZIL 96 83 28 85
NAPROXEN 93 63 29 62
METOPROLOL TARTRATE 91 84 30 13
HYDROCHLOROTHIAZIDE 89 86 31 8
DICLOFENAC SODIUM 88 68 32 78
IBUPROFEN 83 54 33 29
HUMULIN N 73 47 34 443
LIPITOR 71 63 35 89
SERTRALINE HCL 69 64 36 38
AMITRIPTYLINE HCL 64 30 R 37 87
TRIAMCINOLONE ACETONIDE 64 46 37 55
CLONIDINE HCL 62 47 39 59
LABETALOL HCL 61 60 40 300
LEVEMIR 54 39 41 232
ALLOPURINOL 52 49 42 35
SINGULAIR 52 41 42 84
ISOSORBIDE MONONITRATE ER 51 50 44 81
GABAPENTIN 51 28 44 17
ALENDRONATE SODIUM 51 51 44 14
DONEPEZIL HCL 50 50 47 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 10, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.